SMTL ID : 5hd4.1

Dissecting Therapeutic Resistance to ERK Inhibition Rat Wild Type SCH772984 in complex with (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.45 Å
Oligo State
monomer
Ligands
1 x 38Z: (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide(Non-covalent)
3 x SO4: SULFATE ION(Non-functional Binders)
1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Jha, S. et al., Dissecting Therapeutic Resistance to ERK Inhibition. Mol.Cancer Ther. (2016)
Release Date
2016-02-24
Peptides
Mitogen-activated protein kinase 1: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence

2erk.1 | 4qyy.1